🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The brilliant light of our household has faded away for us in this life,” his relatives stated. “After a lengthy and courageous struggle with cancer, we are heartbroken to announce that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his innovative modern soul style and collaborations with high-profile artists.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved No. 4 on the R&B charts, went platinum soon after, and earned multiple Grammy nominations.

However, it was his second album, “Voodoo,” in the year 2000 that propelled his music career into the stratosphere. The record premiered at No. 1 on each of the R&B charts and the main album chart. He received two Grammys: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a icon, albeit a hesitant one, in the public consciousness. The intimate portrayal featured the singer, notably bare to his waist, performing straight into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and openly battled with substance abuse. In 2005, he was part of a serious vehicle accident that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with a further No. 1 debut on the R&B chart and a award for Top R&B Record.

Once more, in his own enigmatic fashion, D’Angelo had limited public outings in the subsequent period.

The singer was announced as a top act for the 2025 Roots Picnic festival, but his appearance was canceled, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s well-being in the months before his passing, he had apparently been in the hospital for an extended period and in hospice for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the deadliest and least preventable forms of the illness, on a gifted artist whose life was ended too soon.

“We are grieved that he can only leave cherished moments with his family, but we are forever thankful for the legacy of extraordinarily moving music he leaves behind,” his kin said.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic cancer affects the digestive organ, a tiny gland that produces the hormone insulin and plays an essential role in breaking down food, among additional roles. The position and dimensions of the pancreas in the body make it more challenging to detect cancer.

Although pancreatic cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is causes seven percent of malignancy fatalities.

Nearly seventy thousand individuals will be diagnosed with this condition and about 52,000 will succumb to the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have few and poor treatment options, and a smaller window to make a significant difference on the well-being of patients,” said a cancer specialist.

Since pancreatic cancer rarely causes early symptoms, it’s often diagnosed only after the condition is advanced. Although a individual has indicators they are often vague and may be confused with a number of common illnesses.

“As of yet, there is no good way to detect pancreatic cancer in the early stages, except for paying attention to physical changes and consulting your physician if there are unfamiliar symptoms,” said a health expert.

Common symptoms of pancreatic cancer include:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• light-colored or greasy stools
• loose stools
• increased appetite or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an outlier, as pancreatic cancer is typically found in adults in the 65 to 75 range. However, numerous malignancies, such as pancreatic cancer, have become increasingly prevalent in younger people.

“This disease diagnosed prior to fifty is deemed rare, yet alarmingly, doctors are beginning to see a rising count of younger patients affected by this disease,” commented a specialist.

Genetic Background Impacts Disease Probability

Without effective screening tools for this malignancy, professionals emphasized the importance of knowing your family’s health background. Some risk factors, such as smoking and obesity also play a role in the onset of pancreatic cancer.

African Americans have the highest incidence of this malignancy in the United States and are more prone to be found to have inoperable cancer.

“The initial action toward lowering one’s risk of pancreatic cancer is understanding individual susceptibility. Individuals should examine their genetic background, genetic background, and medical conditions, such as diabetes, long-term pancreas inflammation, or obesity that may increase their susceptibility,” advised a specialist.

Hereditary risk factors are linked to as much as ten percent of all pancreatic cancer instances. If someone in your household has had this disease, you may want to think about DNA analysis.

“For individuals with a family history of this condition or those having elevated risk DNA changes, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to detect early changes in the organ,” he explained.

For those wishing to reduce their risk, habit adjustments may have an effect. The most effective step you can take to reduce your susceptibility of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.

Excessive alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so limiting or avoiding drinks may help lower your chance.

Controlling your body mass or losing weight may also aid decrease your susceptibility. People with obesity are 20% more likely to get this disease. This malignancy also occurs more often in those with diabetes, and weight loss can also lower the chance of type 2 diabetes.

In spite of this disease’s grim outlook, there is still hope.

“We are making progress with treatments and more recent mixed drug treatments. There are developing precision medicines that already are making an impact,” said a expert.

For numerous individuals, however, education about this rare but {dev